Does treatment duration affect outcome after radiotherapy for prostate cancer? (Q37389911)

20 August 2017

Does treatment duration affect outcome after radiotherapy for prostate cancer? (English)

1 reference

20 August 2017

0 references

1 reference

David J D'Ambrosio

1

1 reference

20 August 2017

Tianyu Li

2

1 reference

20 August 2017

Eric M Horwitz

3

1 reference

20 August 2017

David Y T Chen

4

1 reference

20 August 2017

Alan Pollack

5

1 reference

20 August 2017

Mark K Buyyounouski

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

9 May 2008

1 reference

International Journal of Radiation Oncology Biology Physics

20 August 2017

1 reference

20 August 2017

72

1 reference

20 August 2017

5

1 reference

20 August 2017

1402-1407

1 reference

Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

What dose of external-beam radiation is high enough for prostate cancer?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

A method for increased dose conformity and segment reduction for SMLC delivered IMRT treatment of the prostate

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

An ICRU 50 radiotherapy treatment chart.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763099

Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients

2 September 2018

1 reference

12 December 2020

Extended field (periaortic) irradiation in carcinoma of the prostate--analysis of RTOG 75-06

1 reference

12 December 2020

Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06

1 reference

12 December 2020

Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation

1 reference

12 December 2020

The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy

1 reference

12 December 2020

Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions

1 reference

12 December 2020

An analysis of clinical and treatment related prognostic factors on outcome using biochemical control as an end-point in patients with prostate cancer treated with external beam irradiation

1 reference

12 December 2020

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

12 December 2020

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

12 December 2020

10.1016/J.IJROBP.2008.03.011

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

1 reference